Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adriano Lazzarin

Showing results (51-60 of 328) with videos related to

Pageof 33
Sort By:
Journal of Medical Virology|April 23, 2008
Unexpected dramatic increase in CD4+ cell count in a patient with AIDS after enfuvirtide treatment despite persistent viremia and resistance mutationsAlessandro Soria, Mariangela Cavarelli, Stefania Sala, et al.
AIDS (London, England)|October 28, 2005
Hepatitis C virus populations in the plasma, peripheral blood mononuclear cells and cerebrospinal fluid of HIV/hepatitis C virus-co-infected patientsSabrina Bagaglio, Paola Cinque, Sara Racca, et al.
The New Microbiologica|February 5, 2010
Offer of rapid testing and alternative biological samples as practical tools to implement HIV screening programsMaria Rita Parisi, Laura Soldini, Giovanni Di Perri, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 10, 2003
Pretreatment of chronic active hepatitis C in patients coinfected with HIV and hepatitis C virus reduces the hepatotoxicity associated with subsequent antiretroviral therapyCaterina Uberti-Foppa, Anna De Bona, Giulia Morsica, et al.
AIDS (London, England)|July 17, 2007
Electrocardiographic changes in HIV-infected, drug-experienced patients being treated with atazanavirNicola Gianotti, Monica Guffanti, Laura Galli, et al.
Journal of Neurovirology|October 29, 2002
Epstein-Barr virus DNA load in cerebrospinal fluid and plasma of patients with AIDS-related lymphomaSimona Bossolasco, Paola Cinque, Maurilio Ponzoni, et al.
Clinical Medicine & Research|January 11, 2007
Comparison of an in-house and a commercial RD1-based ELISPOT-IFN-gamma assay for the diagnosis of Mycobacterium tuberculosis infectionPaola Mantegani, Federica Piana, Luigi Codecasa, et al.
The New Microbiologica|September 7, 2007
Comparison of a commercial and an in-house T cell-based assay for the diagnosis of Mycobacterium tuberculosis infectionPaola Mantegani, Federica Piana, Laura Galli, et al.
AIDS Research and Human Retroviruses|January 13, 2004
Evolutionary characteristics of HIV type 1 variants resistant to protease inhibitors in the absence of drug-selective pressureEnzo Boeri, Nicola Gianotti, Filippo Canducci, et al.
AIDS (London, England)|April 20, 2004
Resistance to amprenavir before and after treatment with lopinavir/ritonavir in highly protease inhibitor-experienced HIV patientsHamid Hasson, Nicola Gianotti, Anna Danise, et al.
Pageof 33

Showing results (51-60 of 328) with videos related to

Sort By:
Pageof 33
Journal of Medical Virology|April 23, 2008
Unexpected dramatic increase in CD4+ cell count in a patient with AIDS after enfuvirtide treatment despite persistent viremia and resistance mutationsAlessandro Soria, Mariangela Cavarelli, Stefania Sala, et al.
AIDS (London, England)|October 28, 2005
Hepatitis C virus populations in the plasma, peripheral blood mononuclear cells and cerebrospinal fluid of HIV/hepatitis C virus-co-infected patientsSabrina Bagaglio, Paola Cinque, Sara Racca, et al.
The New Microbiologica|February 5, 2010
Offer of rapid testing and alternative biological samples as practical tools to implement HIV screening programsMaria Rita Parisi, Laura Soldini, Giovanni Di Perri, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 10, 2003
Pretreatment of chronic active hepatitis C in patients coinfected with HIV and hepatitis C virus reduces the hepatotoxicity associated with subsequent antiretroviral therapyCaterina Uberti-Foppa, Anna De Bona, Giulia Morsica, et al.
AIDS (London, England)|July 17, 2007
Electrocardiographic changes in HIV-infected, drug-experienced patients being treated with atazanavirNicola Gianotti, Monica Guffanti, Laura Galli, et al.
Journal of Neurovirology|October 29, 2002
Epstein-Barr virus DNA load in cerebrospinal fluid and plasma of patients with AIDS-related lymphomaSimona Bossolasco, Paola Cinque, Maurilio Ponzoni, et al.
Clinical Medicine & Research|January 11, 2007
Comparison of an in-house and a commercial RD1-based ELISPOT-IFN-gamma assay for the diagnosis of Mycobacterium tuberculosis infectionPaola Mantegani, Federica Piana, Luigi Codecasa, et al.
The New Microbiologica|September 7, 2007
Comparison of a commercial and an in-house T cell-based assay for the diagnosis of Mycobacterium tuberculosis infectionPaola Mantegani, Federica Piana, Laura Galli, et al.
AIDS Research and Human Retroviruses|January 13, 2004
Evolutionary characteristics of HIV type 1 variants resistant to protease inhibitors in the absence of drug-selective pressureEnzo Boeri, Nicola Gianotti, Filippo Canducci, et al.
AIDS (London, England)|April 20, 2004
Resistance to amprenavir before and after treatment with lopinavir/ritonavir in highly protease inhibitor-experienced HIV patientsHamid Hasson, Nicola Gianotti, Anna Danise, et al.
Pageof 33